Eric Ostertag
2021
In 2021, Eric Ostertag earned a total compensation of $6.3M as Executive Chairman and former Chief Executive Officer at Poseida Therapeutics, a 633% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,920 |
|---|---|
| Option Awards | $5,627,347 |
| Salary | $440,246 |
| Other | $9,252 |
| Total | $6,294,765 |
Ostertag received $5.6M in option awards, accounting for 89% of the total pay in 2021.
Ostertag also received $217.9K in non-equity incentive plan, $440.2K in salary and $9.3K in other compensation.
Rankings
In 2021, Eric Ostertag's compensation ranked 2,014th out of 12,415 executives tracked by ExecPay. In other words, Ostertag earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,014 out of 12,415 | 84th |
Division Manufacturing | 766 out of 5,505 | 86th |
Major group Chemicals And Allied Products | 297 out of 2,375 | 88th |
Industry group Drugs | 256 out of 2,096 | 88th |
Industry Biological Products, Except Diagnostic Substances | 80 out of 449 | 82nd |
Source: SEC filing on April 27, 2022.
Ostertag's colleagues
We found three more compensation records of executives who worked with Eric Ostertag at Poseida Therapeutics in 2021.